LLY Q4 2016 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

Q4 2016 Earnings

Reported February 21, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q4 2016	Q3 2016	Q4 2015	QoQ Change	YoY Change
Revenue	$5.8B	$5.2B	—	11.0%	—
Op. Income	$1.1B	$989M	—	6.6%	—
Gross Margin	74.6%	73.0%	—	1.5pp	—
Net Margin	13.4%	15.0%	—	-1.6pp	—
EPS (Diluted)	$0.70	$0.70	—	0.0%	—
Free Cash Flow	$1.7B	$1.4B	—	15.4%	—

Revenue Flow

Item	Amount
REVENUE	$5.8B
Cost of Revenue	$1.5B
GROSS PROFIT	$4.3B
R&D Expenses	$1.5B
Selling & Marketing	$0
General & Administrative	$1.8B
SG&A Expenses	$1.8B
Other Expenses	$0
Operating Expenses	$3.2B
Cost & Expenses	$4.7B
OPERATING INCOME	$1.1B
Interest Income	$32M
Interest Expense	$51M
Other Income/Expenses	-$162M
INCOME BEFORE TAX	$892M
Income Tax Expense	$120M
Net Income from Continuing Ops	$772M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$772M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$772M
D&A	$345M
EBIT	$943M
EBITDA	$1.3B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$5.8B
Cost of Revenue	$1.5B
GROSS PROFIT	$4.3B
R&D Expenses	$1.5B
Selling & Marketing	$0
General & Administrative	$1.8B
SG&A Expenses	$1.8B
Other Expenses	$0
Operating Expenses	$3.2B
Cost & Expenses	$4.7B
OPERATING INCOME	$1.1B
Interest Income	$32M
Interest Expense	$51M
Other Income/Expenses	-$162M
INCOME BEFORE TAX	$892M
Income Tax Expense	$120M
Net Income from Continuing Ops	$772M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$772M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$772M
D&A	$345M
EBIT	$943M
EBITDA	$1.3B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$772M
Depreciation & Amortization	$345M
Stock-Based Compensation	$67M
Deferred Income Tax	$89M
Other Non-Cash Items	$113M
Change in Working Capital	$732M
OPERATING CASH FLOW	$2.1B
Capital Expenditure	-$465M
Acquisitions (Net)	$18M
Purchases of Investments	-$1.6B
Sales/Maturities of Investments	$875M
Other Investing Activities	-$55M
NET CASH FROM INVESTING	-$1.2B
Net Debt Issuance	$1.3B
Common Stock Repurchased	-$300M
Common Dividends Paid	-$541M
Other Financing Activities	-$179M
NET CASH FROM FINANCING	$275M
FREE CASH FLOW	$1.7B
Net Change in Cash	$1.1B

Balance Sheet

Item	Amount
Cash & Equivalents	$4.6B
Short-Term Investments	$1.5B
Net Receivables	$4.8B
Inventory	$3.6B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$15.1B
PP&E (Net)	$8.3B
Goodwill	$4.0B
Intangible Assets	$4.4B
Long-Term Investments	$5.2B
Tax Assets	$0
Other Non-Current Assets	$1.9B
TOTAL NON-CURRENT ASSETS	$23.7B
TOTAL ASSETS	$38.8B
Account Payables	$1.3B
Short-Term Debt	$1.9B
Deferred Revenue	$0
Other Current Liabilities	$6.6B
TOTAL CURRENT LIABILITIES	$11.0B
Long-Term Debt	$8.4B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$0
Other Non-Current Liabilities	$5.4B
TOTAL NON-CURRENT LIABILITIES	$13.7B
TOTAL LIABILITIES	$24.7B
Common Stock	$689M
Additional Paid-In Capital	$5.6B
Retained Earnings	$16.0B
Treasury Stock	-$81M
Accum. Other Comp. Income	-$5.3B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$14.0B
Minority Interest	$73M
TOTAL EQUITY	$14.1B
TOTAL LIABILITIES & EQUITY	$38.8B
Total Debt	$10.3B
Net Debt	$5.7B